The Structural Motifs for Substrate Binding and Dimerization of the α Subunit of Collagen Prolyl 4-Hydroxylase  by Anantharajan, Jothi et al.
Structure
ArticleThe Structural Motifs for Substrate Binding
and Dimerization of the a Subunit
of Collagen Prolyl 4-Hydroxylase
Jothi Anantharajan,1 M. Kristian Koski,1 Petri Kursula,1,2 Reija Hieta,3 Ulrich Bergmann,1 Johanna Myllyharju,3
and Rik K. Wierenga1,*
1Biocenter Oulu and Department of Biochemistry, University of Oulu, P.O. Box 3000, FIN-90014 Oulu, Finland
2Department of Chemistry, University of Hamburg and Centre for Structural Systems Biology, DESY, D-22607 Hamburg, Germany
3Oulu Center for Cell-Matrix Research, Biocenter Oulu and Department of Medical Biochemistry and Molecular Biology, University of Oulu,
P.O. Box 5000, FIN-90014 Oulu, Finland
*Correspondence: rik.wierenga@oulu.fi
http://dx.doi.org/10.1016/j.str.2013.09.005SUMMARY
Collagen prolyl 4-hydroxylase (C-P4H) catalyzes the
proline hydroxylation of procollagen, an essential
modification in the maturation of collagens. C-P4H
consists of two catalytic a subunits and two protein
disulfide isomerase b subunits. The assembly of
these subunits is unknown. The a subunit contains
an N domain (1–143), a peptide-substrate-binding-
domain (PSB, 144–244) and a catalytic domain
(245–517). Here, we report the dimeric structure of
the N-terminal region (1–244) of the a subunit. It is
shown that the N domain has an important role in
the assembly of the C-P4H tetramer, by forming an
extended four-helix bundle that includes an antipar-
allel coiled-coil dimerization motif between the two
a subunits. Complexes of this construct with a
C-P4H inhibitor and substrate show the mode of
peptide-binding to the PSB domain. Both peptides
adopt a poly-(L)-proline-type-II helix conformation
and bind in a curved, asymmetric groove lined by
conserved tyrosines and an Arg-Asp salt bridge.
INTRODUCTION
Collagen is the most abundant protein in animals (Myllyharju and
Kivirikko, 2004; Shoulders and Raines, 2009), being especially
prominent in the skin, where it accounts for three-fourths of the
dry weight. Collagens are characterized by posttranslational
modifications, including extensive hydroxylation of proline resi-
dues. 4-hydroxyproline (Hyp), which is predominantly present
at the Y position of the X-Y-Gly repeats of collagen polypeptides,
is synthesized by collagen prolyl 4-hydroxylase (C-P4H; EC
1.14.11.2; Gorres and Raines, 2010; Myllyharju, 2003, 2008).
This hydroxylation is of critical importance for the stability of
the collagen triple helix. Diseases like scurvy are caused by
insufficiently hydroxylated and unstable collagen, due to the
lack of ascorbate, vitamin C, which is needed for the full activity
of C-P4Hs (Myllyharju, 2003, 2008; Shoulders and Raines, 2009).
Increased collagen formation, accompanied by increasedStructure 21, 2107–21C-P4H activity, is also a cause of various fibrotic diseases (Myl-
lyharju, 2008). Recently, it has been reported that C-P4H activity
also plays a role in breast cancer metastasis (Gilkes et al., 2013).
Therefore, C-P4H is an attractive target for drug discovery
approaches.
Three C-P4H isoenzymes exist in vertebrates, the isoenzyme I
(C-P4H-I) being the most important one (Helaakoski et al., 1995;
Kukkola et al., 2003; Holster et al., 2007). All vertebrate C-P4Hs
are a2b2 tetramers of 240 kDa. They all have the same b subunit,
which is a 55-kDa protein disulfide isomerase (PDI; Appenzeller-
Herzog and Ellgaard, 2008). The precise function of PDI in
C-P4Hs is not known, but it has been shown to be necessary,
at least, to keep the a subunit from aggregating and to retain
the enzyme in the endoplasmic reticulum (ER; Vuori et al.,
1992a, 1992b). The catalytic a subunit varies between the three
isoenzymes. The overall amino acid sequence identities of the
human a(II) and a(III) subunits to the a(I) subunit are 64% and
35%, respectively (Annunen et al., 1997; Kukkola et al., 2003).
The a subunit isoenzymes contain three different domains (Fig-
ure 1A). The first 143 residues of the a subunit (the numbering
scheme refers to the mature protein excluding the 17 signal
sequence residues) is referred to as the N domain (Figure 1A).
Structural and functional information for this domain are
currently lacking. The N domain is followed by a domain known
to be important for the binding of the peptide substrate, and it is,
therefore, referred to as the peptide-substrate-binding (PSB)
domain (Myllyharju and Kivirikko, 1999; Hieta et al., 2003; Fig-
ure 1A). The crystal structure of the PSB domain of human
C-P4H-a(I) (residues 144–244) is known, and it consists of five
a helices, forming two tetratricopeptide repeat (TPR) motifs,
plus a solvating helix (Pekkala et al., 2004; Blatch and La¨ssle,
1999). The catalytic activity locates at the C-terminal catalytic
domain (the CAT domain, 245–517) of the a subunit (Myllyharju
and Kivirikko, 1997). The CAT domain belongs to the non-
heme iron(II), 2-oxoglutarate dependent dioxygenase family,
having the double-stranded b-helix fold, also known as the jel-
ly-roll fold (Koski et al., 2007; McDonough et al., 2010). The
mode of binding of the substrate peptide to the CAT domain is
dominated by two flexible loops folding over the peptide, which
therefore binds in a short tunnel (Koski et al., 2009), which is very
different from the PSB binding groove.
All three vertebrate C-P4H isoenzymes hydroxylate collage-
nous peptides with Pro-Pro-Gly repeats, but substrate affinity18, December 3, 2013 ª2013 Elsevier Ltd All rights reserved 2107
Figure 1. Domain Organization of the a and b Subunits of Human C-P4H-a(I)
(A) The domains of the a(I) subunit are colored as the N domain (gray), PSB domain (pink) and CAT domain (violet). The N domain and the PSB domain together are
referred to as the double domain (DD) of the a(I) subunit. The b subunit consists of four domains (a, b, b0, a0, each colored differently). The linker region between the
b0 and a0 domain is labeled as X.
(legend continued on next page)
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Table 1. SLS and SAXS Data of DD Constructs
Construct Oligomeric State
Theoretical MW
(kDa)
SLS MW
(kDa)
SAXS MW
(kDa) Rga (A˚) Dmax
b (A˚)
Chi Values for Models
(DAMMIN, GASBOR,
BUNCH)
DD1–238 dimer 54 68 57 46 180 0.9, 1.4, 0.8
DD53–238 monomer 21 30 25 27 120 0.6, 0.7, 0.9
Crystal structure (DD1–238) dimer – – – 37 130 –
aRg is radius of gyration.
bDmax is maximum dimension.
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1995; Annunen et al., 1997; Myllyharju and Kivirikko, 1997; Kuk-
kola et al., 2003). Likewise, poly-(L)-proline inhibits C-P4H-I
very effectively in a competitive manner with respect to the
peptide substrate, whereas it inhibits C-P4H-II only at very
high concentrations, and C-P4H-III is apparently inhibited
with intermediate efficiency (Kukkola et al., 2003). The PSB
domain has been shown to be the principal region responsible
for these differences (Hieta et al., 2003). The PSB of the a(I)
subunit has 57% and 35% identity to those of the a(II) and
(III) subunits, respectively (Kukkola et al., 2003; Figure 1B).
The structure of the liganded PSB domain is not known, but
it has been proposed that the peptide binds to a binding groove
lined by solvent-exposed tyrosine residues (Pekkala et al.,
2004). The reason for the affinity differences toward peptide
substrates and poly-(L)-proline inhibitor among the different
C-P4H isoenzymes have remained an open question because
of the lack of structural information for a peptide-liganded
PSB domain.
Here, we report the structure of the N-terminal region (1–244)
of the C-P4H-a(I) subunit, including both the N and the PSB
domain (Figure 1A), and referred to as double domain (DD).
The structures show that the DD forms dimers. The N domain
is responsible for this dimerization, linking two a(I) subunits
together via a four-helix bundle, including a long antiparallel
coiled-coil structure. Crystal structures are also reported for
the DD dimer liganded with a nine-residue collagenous peptide
substrate ((PPG)3) and a nine-residue poly-(L)-proline inhibitor
(P9). Our results reveal the details of themode of binding of these
peptides to the PSB domain, showing how the PSB domain in-
teracts with proline-rich peptides (PRPs).
RESULTS
Solution Structure of the DD Region
The N-terminal DD region of the human C-P4H-a(I) subunit was
studied by a range ofmethods in solution. The DD construct con-
taining residues His1-Glu238 (DD1–238) was found to be most
suitable for structural analysis. Preliminary bioinformatics
studies with COILS (Lupas et al., 1991) indicated that the N-ter-(B) Sequence alignment of the DD region of vertebrate C-P4H a subunits. The am
human (Hs_a_I, Hs_a_II, Hs_a_III), bovine (Bt_a_I, Bt_a_III), rat (Rn_a_I, Rn_a_
secondary structure elements indicated above the sequences are based on the c
the dimerization domain (a1–a6) and the PSB domain (a7–a11) are colored in gray
a helices in the linker region, and the following flexible loop region, are highlight
heptad repeats, are shown by filled red spheres and boxes, respectively. The imp
The conserved aromatic residue cluster and the other residues which form the bin
has been previously predicted to contribute to the substrate specificity of C-P4H
Structure 21, 2107–21minal 50 residues of the a(I) subunit have a high probability to
fold into a coiled-coil. Therefore, also a truncated DD variant
(DD53–238) was made, in order to study the importance of the
N-terminal region for DD dimerization. DD1–238 and DD53–238
eluted as single peaks in size exclusion chromatography (SEC),
and static light scattering (SLS) provided apparent molecular
masses of 68 and 30 kDa, respectively (Table 1). Thus, the
DD1–238 construct is a dimer, while the truncated construct is a
monomer. Further characterization by small-angle X-ray scat-
tering (SAXS) gave similar molecular weights (Table 1). The
maximum dimension and the radius of gyration indicate that
both DD variants are elongated in solution. The ab initio recon-
structed 3D molecular envelope of DD1–238 is Z-shaped and
180 A˚ long, whereas the DD53–238 envelope lacks this shape
and has a length of 120 A˚ (Figure 2; Figure S1 available online).
The N-terminal 52 residues of the C-P4H-a(I) subunit are, thus
required for dimerization of the DD construct, and the N domain
of the a(I) subunit can, therefore, be referred to as the dimeriza-
tion domain. Furthermore, synchrotron radiation circular dichro-
ism (SRCD) data indicate that DD1–238 and DD53-238 are both
highly helical proteins in solution (Figure S1F).
The DD Crystal Structures
Five crystal structures of the DD1–244 and DD1–238 constructs
were obtained (Table 2), while DD53–238 did not crystallize in
any of the tested conditions. The structure of the DD monomer
is similar in all crystal structures (Figures 3 and S2). The root-
mean-square deviation (rmsd) for the Ca atoms between DD
monomers in different crystal forms range between 1.5 and
2 A˚. The relatively high rmsd values are due to the hinge region
between the two domains (Figure S2) as discussed below. At the
N terminus, the 48-residue helix a1 (residues 8–55) protrudes
out from the bulk of the subunit. The C-terminal tip of this helix
is connected via a short helical loop (a2) to two helices (a3,
a4, residues 64–103), which fold back toward the PSB domain.
These two helices, being antiparallel to the long a1 helix, are
referred to as the return helices. The return helix a4 is further
connected to the PSB domain via a linker region (residues
104–143), forming two helices (a5 and a6) and an extended
loop region (Figure 3). The PSB domain (144–244) has five aino acid sequence alignment includes the three C-P4H a subunit isoforms from
III), mouse (Mm_a_I, Mm_a_II, Mm_a_III) and chicken (Gg_a_I, Gg_a_II). The
rystal structure of the DD1–238-(PPG)3 complex (see Figure 3B). The a helices of
and pink respectively. The coiled-coil helix a1 is highlighted with a red box. The
ed with green color. The hydrophobic ‘‘a’’ and ‘‘d’’ positions of the coiled-coil
ortant exceptions of the motif are shown in filled black boxes and are labeled.
ding groove of the PSB domain are shown by filled black arrows. Ile182, which
-I, is marked with an asterisk.
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Figure 2. Structural Characterization of
DD1–238 and DD53–238 in Solution
(A) SAXS data for DD1–238 (blue) and DD53–238
(orange). Shown are also the fits (DD1–238, black;
DD53–238, red) of the built chain-like ab initio
(GASBOR) models. The fits of the corresponding
crystal structures and other models are shown in
Figure S1. Inset: Distance distribution functions for
DD1–238 (blue) and DD53–238 (orange).
(B) Structural models of DD1–238 and DD53–238.
Superimposed are bead-like (DAMMIN) and chain-
like (GASBOR) ab initio models. Further modeling
and comparisons to the crystal structures are
presented in Figure S1.
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Peptide Binding and Dimerization Motif of DD (P4H)helices, which adopt the same TPR fold as previously reported
(Pekkala et al., 2004). The TPR units of all DD structures super-
impose very well on each other (Figure S2), as well as on the pre-
viously determined structure of the separate PSB domain (for
the latter, the rmsd for the 71 (Cys150-Glu220) superimposed
Ca atoms is 0.4 A˚). All five DD structures assemble into the
same Z-shaped dimer, consistent with the Z-shaped solution
structure of DD1–238 (Figures 4A and S1). The long a1 helix forms
an antiparallel coiled-coil structure with the corresponding helix
of the other DD1–238 monomer in the dimer (Figure 4A). Helix a2
is not involved in the monomer-monomer interactions, but the
dimerization contacts are significantly further extended by the
two return helices in such a way that a four-helix bundle dimer-
ization motif (residues 8–103) is formed (Figures 4A and S3).
Finally, helix a5 is also involved in the monomer-monomer inter-
actions (Figure 4B) as described in the next section. This inter-
twined packing arrangement gives rise to a dimer interface of
4,000 A˚2.
The coiled-coil is stabilized mainly by hydrophobic inter-
actions, whereas the four-helix bundle is stabilized by both
hydrophobic and polar interactions (Figure S3). Coiled-coils
are characterized by a repeating seven-residue pattern (abc-
defg)n, with hydrophobic amino acids predominating at posi-
tions ‘‘a’’ and ‘‘d’’ of the heptad repeat (Burkhard et al., 2001).
Most of the residues at ‘‘a’’ and ‘‘d’’ positions in the a1 helix
are hydrophobic and pack in a typical ‘‘knobs-in-holes’’ mode
(Branden and Tooze, 1999), forming the core of the hydrophobic
interactions (Figures 1B and S3A). The exceptions are Glu18 and
Glu32 at position ‘‘d’’ and Thr50 at position ‘‘a.’’ In the DD coiled-
coil, the buried charged residue Glu18, which is highly
conserved in the C-P4H a subunits (Figure 1B) forms a salt
bridge across the dimer interface with Arg73 (of helix a4), and
it is also hydrogen bonded to Trp78 (Figure S3B). Another
exception in the hydrophobic coiled-coil pattern, Glu32, locates
close to the DD dimer 2-fold axis. It is hydrogen bonded to Tyr28
of the same chain, and it also interacts with the positively
charged Lys35 from the same helix as well as from the corre-
sponding helix of the other monomer through water molecules
(Figure S3B). Salt bridges, involving residues Glu33, Glu82,
Lys40, and Arg101, also play a crucial role in the stabilization
of the dimer interface.2110 Structure 21, 2107–2118, December 3, 2013 ª2013 Elsevier Ltd All rights reservedThe Linker Region
The dimerization interactions within the
four-helix bundle (between helices a1,a3, and a4), are complemented by interactions of the linker re-
gion. This region consists of two a helices, a5 and a6, and a
loop following a6 (Figure 4B). This loop (residues 135–144) is
either disordered, or modeled with high B factors (average B
factor ranging from 35 to 122 A˚2), indicating high flexibility (see
Figure S2). In particular, helix a5 participates in dimerization con-
tacts by serving as a stabilization bridge between the four-helix
bundle of the dimerization domain and the PSB domain (Fig-
ure 4B). The hydrophobic side of helix a5, together with a7, forms
a docking site for the return helix a3 of the other subunit. These
hydrophobic interactions are further complemented by many
hydrogen bonds between the side chains of residues from heli-
ces a5 and a7, as well as from a3 of the neighboring subunit (Fig-
ure 4B). Notably, the region around helix a5 has a high amino
acid sequence conservation in different C-P4H a subunit isoen-
zymes (Figure 1B).
The Mode of Binding of (PPG)3 and P9
Three DD-peptide complexes were obtained by co-crystalliza-
tion (Table 2). In the DD1–238-P9 complex, refined at 1.90 A˚ res-
olution, there is only one subunit per asymmetric unit. In both
(PPG)3-complexed DD structures there is a dimer in the asym-
metric unit, but the packing is different. The (PPG)3-complexed
DD1-238 structure (1.90 A˚ resolution, Table 2) was used for further
analysis of the mode of binding of (PPG)3. Both the (PPG)3 and
P9 peptides bind to the same groove of the PSB domain, and
the electron density maps clearly define the directionality of
the bound peptides (Figures 5 and 6) and also show that each
peptide is bound in a distinct way, and not in a range of overlap-
ping modes. The observed directionality agrees with the pre-
dicted topology of the mode of peptide binding (Pekkala et al.,
2004). The (PPG)3 and P9 peptides are actually shifted by one
residue with respect to each other, but the common residues
have similar interactions. Consequently, the first proline in the
P9 peptide has been numbered as Pro0. The protruding four-
helix bundle of the dimerization motif, as well as the linker region,
does not participate in peptide-PSB interactions (Figure 5). Pep-
tide binding has no significant effect either to the overall fold of
the PSB domain (see Figure S2) or to that of the DD dimer. The
peptide binding groove is lined by the side chains of six tyrosine
residues, Tyr158, Tyr193, Tyr196, Tyr199, Tyr230, and Tyr233,
Table 2. Crystallographic Data and Refinement Statistics
Data Set SeMet-DD1–238-apo DD1–238-apo DD1–238- (PPG)3
a DD1–244-(PPG)3 DD1–238-P9
Crystallization
Crystallization
condition
26%–29%
PEGMME 2000
25%–30% PEG 400 10% PEGMME 5000 10% PEGMME 5000 20% PEG 6000
0.2 M KSCN 10% Isopropanol
100 mM HEPES, pH 7.5
10% DMSO 10% DMSO 0.1 M Bicine, pH 9.0
5 mM spermine-HCl 5 mM spermine-HCl 6% MPD 10% MPD 5 mM spermine-HCl
5 mM DTT – 0.1 M MES, pH 6.0
5 mM spermine-HCl
100 mM MES, pH 6.0
Peptide concentration – – 5 mM 5 mM 5 mM
Cryo used 5% glycerol 10% glycerol 12.5% glycerol 19% glycerol 10% glycerol
Data Collection
Beamline ID14-4, ESRF ID29, ESRF 911-3, MAX-lab X12, EMBL-DESY In house, X8 PROTEUM
Wavelength (A˚) 0.974 0.970 1.000/1.500 0.899 1.574
Detector Q315r ADSC Pilatus 6M MARCCD MARCCD Pt-135 CCD
Unit cell parameters a = 104.9 A˚ a = 71.9 A˚ a = 72.2 A˚ a = 234.6 A˚ a = 76.9 A˚
b = 72.0 A˚ b = 105.4 A˚ b = 100.9 A˚ b = 47.9 A˚ b = 53.0 A˚
c = 66.4 A˚ c = 65.9 A˚ c = 68.4 A˚ c = 60.3 A˚ c = 79.9 A˚
a = g = 90.0, b = 91.7 a = b = g = 90.0 a = b = g = 90.0 a = b = g = 90.0 a = g = 90.0, b = 95.8
Space group C2 P21212 P21212 P21212 C2
Resolution range (A˚) 45.00–3.00
(3.07–3.00)
48.60–2.20
(2.33–2.20)
40.00–1.90
(1.95–1.90)
35.00–2.95
(3.05–2.95)
43.60–1.90
(1.94–1.90)
Vm (A˚
3/Da) 2.38 2.34 2.34 2.30 2.83
Molecules per AU 2 2 2 2 1
Redundancy 3.7 (2.6) 4.0 (3.8) 19.5 (4.7) 5.01 (5.1) 13.26 (6.0)
Completeness (%) 96.7 (73.9) 98.4 (97.6) 99.9 (99.8) 99.5 (99.1) 99.2 (94.0)
<I/s(I)> 13.0 (2.9) 15.9 (2.3) 21.9 (2.4) 15.01 (2.3) 24.9 (2.46)
Rmerge (%) 7.8 (33.1) 4.7 (52.6) 9.2 (57.7) 8.2 (75.6) 6.6 (47.0)
Wilson B (A˚2) 50.9 57.8 34.7 66.9 28.3
Refinement
Resolution (A˚) 44.00-3.00 48.60-2.20 58.8-1.90 33.8-2.95 30.26-1.90
Rwork (%) 20.9 21.8 17.4 22.6 18.2
Rfree (%) 27.7 26.1 22.3 27.9 23.5
Number of reflections 19,054 25,785 40,148 16,880 25,400
Number of atoms 3,661 3,778 4,197 3,692 2,178
protein 3,652 3,696 3,861 3,642 1,896
(PPG) 3 – – 55 (bound to A) 50 (bound to A) –
(P) 9 – – – – 64 (bound to A)
Waters 9 82 281 – 218
Geometry Statistics (rmsd)
Bond lengths (A˚) 0.007 0.009 0.007 0.012 0.009
Bond angles () 1.50 1.18 0.93 1.80 1.13
Average B-factor (A˚2)
Protein atoms 46.0 64.0 30.8 129.4 30.0
Ligand atoms – – 41.7 132.9 32.1
Waters 28.1 44.3 38.1 35.8
Ramachandran Plot
Favored 94.0 96.9 98.8 98.2 97.9
Additionally allowed (%) 6.0 2.7 1.2 1.6 2.1
Generously allowed (%) 0.0 0.4 0.0 0.2 0.0
PDB ID 2YQ8 4BT8 4BT9 4BTA 4BTB
The numbers in parentheses refer to the highest-resolution shell. AU, asymmetric unit.
aMerged data collected from two crystals (Table S2).
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Figure 3. The Monomeric Structure of the DD Region of the C-P4H-
a(I) Subunit
(A) Detailed domain structure of the DD region of the C-P4H-a(I) subunit based
on its crystal structure shown in (B). The following color codes are used to
represent the structural regions of the dimerization domain: coiled-coil, red;
return helices, gray; linker region, green; PSB domain, pink.
(B) A cylindrical cartoon diagram of the crystal structure of monomeric DD1–238
subunit. The structure is all helical consisting of 11 a helices, except for
DD1–238-P9, which lacks the short a2 (see also Figure S2). The PSB domain
with bound (PPG)3 peptide (yellow sticks) consists of two TPR units (helices
a7–a10) with a solvating helix a11. The arrow marks the flexible loop of the
linker region.
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Peptide Binding and Dimerization Motif of DD (P4H)as well as by Phe231, Asn227, and by a salt bridge formed
between Asp192 and Arg223 (Figure 5). Tyr233, Tyr230, and
Tyr196 form a shallow aromatic surface, with stacking interac-
tions to the outward pointing prolines (Figures 6A, 6B, S4, and
S5). The exit region of the groove that binds the C-terminal
part of the peptide is curved downward (Figure 5). This extended
part of the groove is shaped by the side chains of Tyr158, Tyr193
and Tyr196, and by the salt bridge between Arg223 and Asp192.
Pro8 is deeply buried in this pocket, and it is also stacked against
the salt bridge (Figures 6 and S4). The interactions between the
conserved tyrosines and peptidyl prolines are further comple-
mented by only a few hydrogen bonds (Figure 6). Direct
hydrogen bonds from the peptide to the PSB domain occur
only in the C-terminal end of the peptides. In addition, both com-
plexes contain several water molecules interacting with the
peptide. Interestingly, the water molecule network is different
between the two peptide-bound complexes (Figure 6).
The precise conformation of the two bound peptides is not the
same (Figure 6C). The inward pointing Pro5 and Pro8 superim-
pose well on each other. However, near the residues at positions
6 and 7, as well as near the N terminus of the peptides, there are2112 Structure 21, 2107–2118, December 3, 2013 ª2013 Elsevier Ltdstructural differences. The phi and psi angles of the peptides
range from50 to –80 and from 140 to 170, respectively (Ta-
ble S1). Thus, they adopt the canonical poly-(L)-proline-type-II
helix (PPII) conformation, as generally observed for PRPs (Ball
et al., 2005), including the single collagenous peptide chain in
the collagen triple helix. The most deviating dihedral value from
the canonical PPII conformation is noted for Gly3 (4 = 113).
An important feature of the (PPG)3 peptide is the NH group of
the glycine, which can act as a hydrogen bond donor, and which
is absent in the P9 peptide. In the (PPG)3-DD complex, water
molecules Wat64 and Wat252 are hydrogen bonded to the NH
groups of Gly6 and Gly3, respectively (Figure 6A). In the P9-DD
complex, the corresponding proline side chains (Pro6 and
Pro3) of the peptide replace these water molecules. Also
Wat206, which bridges between the carbonyl oxygen of Gly3
and the side chain of Asn227 in the (PPG)3 complex is replaced
by Pro3 in the P9 structure. Interestingly, the Arg223 side chain
adopts a different rotamer in the two (PPG)3 and P9-complexed
crystal structures, but the salt bridge with Asp192 is preserved
(Figure 6). From the analysis of the mode of peptide binding to
the PSB domain, it appears that the C-terminal Pro5 and Pro8
residues provide the anchoring motif, whereas the N-terminal
part of the peptide is more loosely bound.
Calorimetric Analysis of Peptide Binding
The crystal structures show interesting differences in the interac-
tions between P9 and (PPG)3, with respect to the hydrogen
bonding networks and hydrophobic interactions. Therefore,
isothermal titration calorimetry (ITC) was carried out with both
peptides to quantify the peptide-protein interactions (Figure 7
and Table 3). The results agree with a 1:1 binding stoichiometry
for both complexes, showing that both PSB domains in the DD
dimer bind a peptide molecule in solution. The Kd for the
(PPG)3 complex is 144 mM, indicating a moderate binding affinity
toward the substrate peptide. Previously, it has been shown that
longer PPG repeat peptides, (PPG)5 and (PPG)10, bind tightly to
the PSB domain with Kd values of 100 and 50 mM, respectively,
whereas (PPG)2 has weak affinity (Kd 5,000 mM; Hieta et al.,
2003). Our results with the DD dimer agree with the PSB domain
having higher affinity toward longer (PPG)n peptides. Interest-
ingly, according to our ITC measurements, the P9 inhibitor
(having a Kd of 9.8 mM) has 15-fold higher affinity to the DD
construct than (PPG)3 (Table 3). The affinity of the P9 peptide
is similar to that previously found for the affinity of a 45-residue
poly-(L)-proline for C-P4H-I and its separate PSB domain (Kd
4 mM) (Hieta et al., 2003). The thermodynamic profiles obtained
for P9 and (PPG)3 are very different (Figure 7C). The thermody-
namic data highlight that the enthalpy contribution to the binding
is much more favorable for (PPG)3 binding (by 8.7 kcal/mol),
whereas for the entropy contribution, the opposite trend is
noticed, much more favoring P9 binding (by 10.2 kcal/mol).
The net effect of these enthalpy and entropy differences results
in stronger binding of the P9 peptide (by 1.5 kcal/mol).
DISCUSSION
The structure and function of the N domain of the C-P4H-a(I)
subunit (residues 1–143) have been elusive so far, as this domain
shows no amino acid sequence similarity to any known protein orAll rights reserved
Figure 4. The Dimeric Structure of the DD
Region of C-P4H-a(I) Subunit
(A) A stereo image of the Ca-trace of the DD1–238
intertwined dimer, viewed down the 2-fold axis of
the dimer, shows the four-helix bundle dimeriza-
tion motif (see also Figure S3). The dimeric struc-
ture of DD1–238-P9 complex was generated using
symmetry operation and the monomeric chains of
DD are colored in yellow and blue, respectively.
The P9 peptide bound to the PSB domain is shown
in magenta. The N and C termini of the subunits
and the peptide are labeled.
(B) Stereo image of the linker region of the DD1–238-
P9 structure. The figure highlights helix a5 (green)
and its hydrogen bond network with the PSB
domain (in particular helix a7, pink) and the
dimerization domain of the other subunit (in
particular the return helix a3, gray). The side chains
of Gln110, Lys115 and Gln121 are hydrogen
bonded and salt bridged to Glu152 (in a7), Glu160
(in a loop between a7 and a8) and Trp169 (in a8) of
the PSB domain, respectively. The Gln121-Trp169
interaction is very likely present in all C-P4H a
subunit isoforms, because these residues are
highly conserved (Figure 1B). Furthermore, direct
hydrogen bond interactions also exist between the
PSB domain and the return helix a3 of the neigh-
boring subunit. Shown are also some highly
conserved polar residues in the solvent exposed
side of a5 (Glu108, Asp109, Arg119, Thr123), the
function of which is not revealed by the crystal
structures.
Structure
Peptide Binding and Dimerization Motif of DD (P4H)domain. The crystal structure of the dimeric DD1–238 shows
an extensive dimer interface between the two N domains
(4,000 A˚2), indicating that the N domain functions as a dimeriza-
tion domain between two a(I) subunits. The arrangement of the
DD dimer is dominated by a long left-handed antiparallel
coiled-coil assembly, completed by two return helices (Fig-
ure 4A). Coiled-coil helices, in general, play an important role in
the oligomerization of proteins (Lupas and Gruber, 2005).
According to the DALI server (Holm and Rosenstro¨m, 2010),
the most similar structure concerning the C-P4H N domain re-
gion 8-103 is found in the inhibitor of growth 4 (ING4) protein
(Protein Data Bank [PDB] ID 4AFL), which also has an N-terminal
helical region, forming an antiparallel four helix bundle dimeriza-
tion motif (Culurgioni et al., 2012). ING4 has two long coiled-coil
helices, which in the dimer, form a four-helix bundle of two
coiled-coils. The dimeric DD assembly, in which the return
coiled-coil helix (as seen in ING4) is replaced by two shorter a he-
lices (the return helices a3 and a4), is, to the best of our knowl-
edge, not observed in any protein-protein dimerization interface.
A number of salt bridges further stabilize the DD four-helix
bundle dimerization interface (Figure S3B). Because the key res-
idues for the formation of the coiled-coil and the complete four-
helix bundle are conserved in all C-P4H isoforms (Figure 1B), the
mode of dimerization of the a subunits is most likely the same in
all vertebrate C-P4H heterotetramers. The C-P4H a subunit is
the only member of the 2-oxoglutarate dependent dioxygenase
family, in which such a four-helix bundle dimerization motif of
coiled-coil and return helices has been identified (McDonoughStructure 21, 2107–21et al., 2010). The importance of the long coiled-coil helix a1 for
the dimerization of the DD region is evident, because the
absence of this helix results in a monomeric protein (Figure 2B;
Table 1). SAXS and SRCD analyses suggest that residues
Ala53-Tyr103, i.e., the return helices a3 and a4, are folded in
the truncated construct lacking the coiled-coil, but adopt a
different conformation than in the complete DD1–238 dimer (Fig-
ures 2 and S1). The overall Z shape of the DD dimer is similar
in the crystal and solution structures, although the molecule is
somewhat more elongated in solution (Figure S1). The small
shape differences between the solution and crystal structures
correlates with a small hinge motion of the linker region between
the dimerization and PSB domains (Figure S2).
The Mode of Binding of the (PPG)3 Substrate to the PSB
Domain
Crystallographic binding studies were done with a synthetic
peptide substrate, (PPG)3, which mimics the X-Pro-Gly repeats
present in the procollagen polypeptide chains (Shoulders and
Raines, 2009). The peptide substrate is bound in a groove, as
proposed earlier (Pekkala et al., 2004). A 3-fold repeat of the
Pro-Pro-Gly motif (nine residues) fits optimally in the binding
groove of the PSB domain, while a six-residue peptide with a
2-fold repeat of the Pro-Pro-Gly motif cannot fully exploit all
possible interactions in the PSB binding groove. As seen in
other PRP complexes (SH3, WW, GYF, EVH1, profilin, and
UEV; Ball et al., 2005), the PSB domain also utilizes conserved
aromatic residues to recognize the PPII helix of PRPs. The18, December 3, 2013 ª2013 Elsevier Ltd All rights reserved 2113
Figure 5. The Peptide Binding Groove of the PSB Domain of the
C-P4H-a(I) Subunit
A Surface representation showing the PSB domain of the (PPG)3 liganded DD
structure. The peptide (shown as sticks) and the highly conserved residues
shaping the groove are explicitly shown. The terminal residues (Pro1, Gly9),
and the anchoring residues (Pro5, Pro8) of the peptide are also labeled. The
following color code is used for the surface representation of the first monomer
of the DD dimer: red (coiled-coil), light brown (return helices), green (linker
region) and pink (PSB domain). Also included (marked by a star) is the return
helix a3 of the second monomer of the DD dimer (light brown). Ile182, which
has been predicted to contribute to the substrate specificity of C-P4H-I, is also
shown and labeled. See also Figure S4.
Structure
Peptide Binding and Dimerization Motif of DD (P4H)curved peptide-binding groove of the C-P4H-I PSB (Figure 5) is
more asymmetric than the classical, rather flat, binding pockets
for PRPs, such as those in SH3 domains (Macias et al., 2002). In
many PRP-protein complexes, direct hydrogen bonds are
observed between the backbone carbonyl oxygen atoms of
the peptide and the tyrosine hydroxyl groups or the amino
groups of tryptophan and histidine side chains of the binding
protein (Ball et al., 2005); but there are no water-mediated inter-
actions in these PRP-protein complexes. Conversely, in the PSB
domain complexes, only a few direct hydrogen bond interac-
tions between the PSB and (PPG)3 are present. Instead, the
complex is stabilized by water-mediated hydrogen bonding in-
teractions, in addition to hydrophobic interactions (Figure 6).
The bound peptide has the same directionality in all the three
peptide-liganded DD structures. In other PRP-binding modules,
also characterized by an aromatic binding surface, the proline-
rich ligandscanoften becomebound in both orientations (Macias
et al., 2002; Mahoney et al., 1999; Zarrinpar and Lim, 2000). The
asymmetric mode of binding of (PPG)3 to the PSB domain, being
bound in the shallow groove as well as the exit tunnel, apparently
prevents promiscuity of peptide binding. The inwardpointing res-
idues, in particular Pro5 and Pro8, anchor the peptide into the
binding groove (Figures 5 and S4). These prolines (including
Pro2) actually precede the glycine residue (Y position prolines)
and will eventually be hydroxylated by the CAT domain of
C-P4H. The fact that these Y prolines are inserted into hydropho-
bic pockets in the complexes (Figure S4) explains the weak affin-
ity of the PSB domain toward hydroxylated (PPG)n products
(Hieta et al., 2003). Proline residues at the X position of the
(PPG)3 peptide, instead, all point to the bulk solvent. It is inter-
esting to point out that in the natural pro-collagen polypeptide
substrates, the X position can be occupied by almost any amino
acid residue (Piez, 1976). In our previous studies, it was shown2114 Structure 21, 2107–2118, December 3, 2013 ª2013 Elsevier Ltdthat the tyrosine residues lining the peptide-binding groove of
the PSB are important for the binding of (PPG)10 (Pekkala et al.,
2004); especially Tyr193, Tyr196, and Tyr230 were of critical
importance. The PSB-(PPG)3 complex structure reveals that
these aromatic residues are indeed central for binding of the pep-
tide by forming CH-p interactions (Bhattacharyya and Chakra-
barti, 2003) with several proline residues of the peptide substrate
(Figure S5 and Table S1). They are also involved in the formation
of the binding pocket for the anchoring residues Pro5 and Pro8.
The Mode of Binding of the P9 Inhibitor to the PSB
Domain
Poly-(L)-proline is a competitive inhibitor of C-P4H-I with respect
to the peptide substrate, and it is known to bind to the PSB
domain (Myllyharju and Kivirikko, 1997; Hieta et al., 2003). In
this study, the short poly-(L)-proline peptide P9 was used for
calorimetric and crystallographic binding studies. Interestingly,
P9, an inhibitor, has a 15-fold higher affinity than (PPG)3, the sub-
strate, to the DD variant (Table 3; Figure 7). The higher affinity for
P9 correlates with significant differences, as compared to the
(PPG)3 complex, in the hydrogen-bonding network between
PSB and the peptide. There are also side chain rotations of the
residues lining the peptide binding groove, in particular of
Tyr233, Tyr230 and Tyr196 being stacked with respectively
Pro1, Pro4, and Pro7 of P9 (Table S1; Figure 6C). The proline
residues in P9 replacing the glycines in (PPG)3 peptide do not
participate in stacking interactions in the P9 complex, but the in-
teractions of the other proline residues with the PSB binding
groove (Pro1, Pro4, Pro5, Pro7, Pro8) appear to be more optimal
(Figure S5 and Table S1). In addition, in the P9 complex, one
strong hydrogen bond (2.6 A˚) exists between the PSB and the
peptide, from the Tyr158 hydroxyl group to the carboxyl oxygen
of Pro8. In the (PPG)3 complex, the Tyr158 hydroxyl group inter-
acts with the peptide via a water-mediated hydrogen bond (Fig-
ure 6). Direct hydrogen bonds also exist in the (PPG)3 complex
with the Arg-Asp salt bridge. However, these hydrogen bonds
are weak (3.5 A˚), and they are formed with the C terminus of
the peptide, which is not clearly defined in the electron density
(Figures 5 and 6A). The more favorable entropic contribution of
the P9 mode of interaction, as compared to (PPG)3 (Figure 7
and Table 3), correlates with the different water structure in the
complex, since more water molecules are released on binding
P9 (less water-mediated hydrogen bonds between the peptide
and the PSB). The more favorable entropic term for P9 binding
also agrees with less entropic loss on binding because of the
higher conformational restraints of the P9 peptide in solution.
Substrate Affinity
Differences in theaminoacid compositionof thePSBdomains are
believed tobe themain reason for thesubstrateaffinitydifferences
of the three vertebrateC-P4H isoenzymes (Hieta et al., 2003; Kuk-
kola et al., 2003). The residues lining the peptide bindinggrooveof
the PSBarehighly conserved especially inC-P4Hs I and II, except
for Tyr233, which is replaced by Gln, Arg or Lys in C-P4H-II (Fig-
ure 1B). This difference has been proposed to be themain reason
for the fact that poly-(L)-proline is not an effective inhibitor for C-
P4H-II (Annunen et al., 1997; Helaakoski et al., 1995; Myllyharju
and Kivirikko, 1999). Because the (PPG)3 peptide takes a slightly
curved conformation when bound to the groove, its N-terminalAll rights reserved
Figure 6. Peptide Binding Mode of (PPG)3 and P9 to the PSB Domain of the C-P4H-a(I) Subunit
(A) The peptide-protein interactions of the DD1–238-(PPG)3 complex structures. The representative (Fo-Fc) omit electron density, (contoured at 1.0 s), is also
shown for the (PPG)3 peptide. Direct and water mediated hydrogen bonds between the peptide and the protein are colored in green and black dashed lines,
respectively. The Asp192-Arg223 salt bridge is shown in magenta (see also Figure S5A).
(B) The (Fo-Fc) omit electron densitymap (contoured at 1.0 s) and the peptide-protein interactions for P9. Hydrogen bonding network is colored as in (B). See also
Figure S5B.
(C) Superimposition of the peptide binding sites of DD1–238-(PPG)3 (yellow), DD1–238-P9 (blue), and the apo structure of the PSB domain (pink, PDB-ID 1TJC). The
different positions of the tyrosine side chains lining the peptide binding groove are clearly visible. Also depicted is the slightly different mode of binding of the
(PPG)3 and P9 peptides. The hydrogen bonding networks of the binding groove in both peptide bound structures are shown using the same color code as (B) and
(C). Highlighted are W187 (black asterisk), which is conserved in all three structures, and W154 (green asterisk), which have similar interactions in the two ligand
bound structures.
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Peptide Binding and Dimerization Motif of DD (P4H)prolines are not closely interacting with the side chain of Tyr233.
Instead, theP9peptide isbound in amoreextendedconformation
(seeFigure6C), andPro1 formsaCH-p interactionwith theTyr233
side chain (Figure S5 and Table S1). It is evident that the replace-
ment of Tyr233 by a residue with a nonaromatic side chain dis-
rupts this stacking interaction. Therefore, the replacement of
Tyr233 may severely reduce the binding of the rigid poly-(L)-pro-
line peptide to the PSB domain of C-P4H-a(II). Ile182, which has
also been proposed to play a role in the substrate affinity differ-
ences betweenC-P4H-I and II (Myllyharju andKivirikko, 1999), lo-
cates far from the peptide binding groove (Figure 5), suggesting
that its direct role in peptide binding is minor.
It has been shownearlier that both theC-P4H-I tetramer and its
PSB have a weak affinity (Km and Kd) for (PPG)2 (in the millimolar
range), but have high affinity for (PPG)5 and (PPG)10, (in themicro-
molar range; Hieta et al., 2003). The peptide-binding groove of
the PSB domain is optimal for binding a peptide with three trip-
lets. Our data, thus, suggest that the higher affinity of (PPG)5
and (PPG)10 is possibly related to the solution properties of theStructure 21, 2107–21longer PPG repeats. Our liganded structures show that the PPII
conformation is essential for tight binding of the peptide to the
PSB domain, due to optimal CH-p interactions between the pep-
tidyl prolines and the tyrosine residues lining the peptide binding
groove. Longer collagenous peptidesmay have a higher propen-
sity for the PPII conformation, resulting also in a higher affinity.
Conclusions
The structure of the dimeric DD region of the C-P4H-a(I) subunit
provides a better understanding of the structure-function rela-
tionships of the C-P4H tetramer. Our data show the importance
of the N-terminal domain (residues 1–143) of the a(I) subunit for
the dimerization of the two a subunits, and therefore being
important for the oligomerization of the complete C-P4H hetero-
tetramer. The structure also reveals the details of the mode of
binding of PRPs to the PSB domain in the DD. The relative affin-
ities of the substrate (PPG)3 and the inhibitor P9 for the DD region
show that the substrate specificity of C-P4H is determined by the
catalytic domain: despite the high affinity of the PSB domain for18, December 3, 2013 ª2013 Elsevier Ltd All rights reserved 2115
Figure 7. Calorimetric Analysis of Binding of
(PPG)3 and P9 to the DD1–238 of Human
C-P4H-a(I) Subunit
(A and B) The isothermal calorimetry experiments
for the binding studies of (PPG)3 (A), and P9 (B)
were carried out by injecting 1 mM peptide solu-
tions into a 50 mM of DD1–238 protein sample
solution. The top panel shows the raw data and the
bottom panel shows the calorimetric binding
isotherm. The Kd values are 144 mM and 9.8 mM for
(PPG)3 and P9, respectively. The titration profile
for both peptides shows that the reaction is
exothermic but saturation is not reached in the
case of (PPG)3 due to the weaker affinity.
(C) Depiction of the thermodynamic data of the
binding of (PPG)3 and P9, as listed in Table 3.
Structure
Peptide Binding and Dimerization Motif of DD (P4H)P9, this peptide cannot be hydroxylated by the catalytic site of
C-P4H-I. C-P4H is regarded as an attractive target for the devel-
opment of inhibitors for use as effective therapeutics. Thus,
detailed structural and thermodynamic information of peptide
binding to its PSB domain, as provided here, are very valuable
for the design of potent C-P4H inhibitors.
EXPERIMENTAL PROCEDURES
Construction, Expression, and Purification of the C-P4H-a(I) Subunit
DD Variants
Various truncated constructs having the N-terminal DD half of the a(I)
subunit of C-P4H were generated using standard molecular biology tech-Table 3. Calorimetric Data of the DD1–238 Construct Binding
Studies
Peptide Kd (mM) DH (cal/mol) TDS (cal/mol) DG (cal/mol)
(PPG)3 143.5±10.5 15,545±245 10,295±283 5,250±39
P9 9.8±0.2 6,884±22 55±41 6,829±20
2116 Structure 21, 2107–2118, December 3, 2013 ª2013 Elsevier Ltd All rights reservedniques using the human C-P4H a(I) subunit cDNA
as a template. The His-DD1–244 construct,
including an N-terminal His6-tag, was the first
studied construct of DD, and was purified with
Ni-loaded chelating sepharose Fast flow (GE
Healthcare) followed by SEC. SEC was performed
using a Superdex 75 column equilibrated with
50 mM Tris-HCl (pH 8.5), and the protein contain-
ing fractions were collected. The His-tag was
removed using Tobacco Etch Virus (TEV) protease
(AcTEV, Invitrogen), and the cleavage reaction
required approximately 1.5 mg of TEV to cleave
20–30 mg of His-DD1–244 in 50 mM Tris-HCl
(pH 8.5) containing 2 mM b-mercaptoethanol.
The DD1–244 was purified from the His6-tag and
the His-tagged TEV using Ni-loaded chelating
Sepharose Fast flow (GE Healthcare) in 50 mM
Tris-HCl (pH 8.5), 0.3 M NaCl, 20 mM imidazole
buffer. As a final step, the protein was cleaned by
repeating the SEC step using Tris-HCl (pH 8.5)
buffer. The purification of the nontagged DD vari-
ants (DD1–238, DD53–238) was initiated by a DEAE
anion exchange chromatography, followed by
HiTrapQ anion exchange chromatography and
SEC using 10 mM Tris-HCl (pH 8.5), 100 mM
NaCl, and 100mMglycine (storage buffer). Full de-
tails of the preparation of the DD constructs, aswell as their expression and purification protocols can be found in the
Supplemental Experimental Procedures.
Characterization of the DD1–238 and DD53–238 Variants Using SLS,
SAXS, and SRCD
DD1–238 and DD53–238 variants, dissolved in storage buffer, were characterized
with SLS, SRCD, and SAXS. The SLS measurements were performed using a
miniDAWN TREOS multiangle light scattering detector (Wyatt Technology),
connected to A¨kta Purifier purification equipment (GE Healthcare). SRCD
data were collected on the CD1 beamline at the ASTRID storage ring (ISA,
Aarhus, Denmark). SAXS data were measured using synchrotron radiation at
MAX-lab (Lund, Sweden), beamline I711, and data were analyzed using pro-
grams of the ATSAS package (Konarev et al., 2006). Details of these experi-
ments can be found in the Supplemental Experimental Procedures.
Crystallographic Studies on DD Constructs
All the DD variants were targeted to extensive crystallization screening, as
described in the Supplemental Experimental Procedures. All the crystal
forms were obtained by using various polyethylene glycols (PEGs) or polye-
thelene glycol monomethyl ethers (PEGMMEs) as major precipitation agents
(Table 2). The DD1–244 variant, (made by removal of the His-tag with (TEV)
protease), formed needle-shaped crystals in the co-crystallization
Structure
Peptide Binding and Dimerization Motif of DD (P4H)experiments with (PPG)3. X-ray diffraction data were collected to 2.95 A˚ res-
olution at the synchrotron beamline X12 (EMBL/DESY, Hamburg, Germany).
This crystal form is referred to as DD1–244-(PPG)3. The DD1–238 variant
generated better diffracting crystals when crystallized in the presence of
spermine-HCl. Data for the best apo crystal form (referred to as DD1–238-
apo), diffracting to 2.2 A˚, were collected at the synchrotron beamline ID29
(ESRF, Grenoble, France). The same construct was also co-crystallized
with (PPG)3 and P9 (referred to as DD1–238-(PPG)3 and DD1–238-P9, respec-
tively). The high-resolution data set of DD1–238-(PPG)3 (1.90 A˚) was collected
at the synchrotron beamline I911-3 (MAX-lab, Lund, Sweden; Table S2). The
final high-resolution data set used for the model building and structure refine-
ment (Table 2), was obtained by merging this data set with a highly redun-
dant data set collected from another crystal (Table S2). The DD1–238-P9
(1.90 A˚) data set was collected using an in-house X8 PROTEUM diffraction
system (Bruker; Table 2). The initial structure of the DD dimer was solved us-
ing 3.0 A˚ X-ray data collected from a single SeMet-DD1–238 crystal using the
selenium absorption peak wavelength 0.974 A˚ at the ID14-4 beamline (ESRF,
Grenoble, France). The phases were solved using a combination of molecular
replacement (MR) using Phaser (McCoy et al., 2007) and single wavelength
anomalous dispersion (SAD) methods with the Auto-Rickshaw program
package (Panjikar et al., 2009). The structures of the other DD crystal forms
were determined using MR with SeMet-DD1–238 as a model. The data collec-
tion and refinement statistics are presented in Table 2. Full details of crystal-
lization, data collection, structure determination, refinement, and validation
can be found in the Supplemental Experimental Procedures. The DD53–238
variant could not be crystallized.Isothermal Titration Calorimetry
Isothermal titration calorimetry experiments were performed to study peptide
binding to the DD1–238 construct using an ITC-200 titration microcalorimeter
(GE Healthcare). The data were collected and analyzed using the Origin
software package (Microcal). Details of these experiments can be found in
the Supplemental Experimental Procedures.ACCESSION NUMBERS
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